Recombinant FCRL5 (Cevostamab Biosimilar) anticorps
Cet anticorps Humanized Monoclonal détecte spécifiquement FCRL5 (Cevostamab Biosimilar) dans ELISA et FACS. Il présente une réactivité envers Humain.
1 image
N° du produit ABIN7490924
Aperçu rapide pour Recombinant FCRL5 (Cevostamab Biosimilar) anticorps (ABIN7490924)
Antigène
FCRL5 (Cevostamab Biosimilar)
Type d'anticorp
Recombinant Antibody
Reactivité
Humain
Hôte
Humanized
Clonalité
Monoclonal
Application
ELISA, Flow Cytometry (FACS)
Classe de qualité
Research Grade
-
-
Fonction
- Anti-FCRL5 (cevostamab biosimilar without anti-CD3 portion) mAb
-
Attributs du produit
- BFCR-4350-A, BFCR-4350A, RG-6160, RO-7187797
-
Purification
- Purified from cell culture supernatant by affinity chromatography
-
Isotype
- IgG1
-
-
-
Indications d'application
- ELISA 1:5000-10000, Flow Cyt 1:100
-
Commentaires
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute with deionized water
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Date de péremption
- 12 months
-
-
- FCRL5 (Cevostamab Biosimilar)
-
Classe de substances
- Biosimilar
-
Sujet
- Synonyms: BXMAS1, CD307, CD307e, FCRH5, IRTA2, PRO820
-
UniProt
- Q96RD9
Antigène
-
Vous êtes ici:
